Imagene AI Hits $45M in Total Funding After Completing $23M Series B Led by Larry Ellison

Imagene AI delivers a living intelligence engine for adaptive, insight-driven precision medicine. MIAMI, - Imagene AI, a pioneer in multi‑modal foundation models for precision medicine, today announced the successful close of a $23 million Series B financing round led by Oracle Chairman and CTO Larry Ellison. This latest infusion brings Imagene AI's total capital raised [...]

Siemens completes acquisition of Dotmatics

• Acquisition successfully closed for enterprise value of $5.1 billion • Siemens expands AI-powered Siemens Xcelerator portfolio with end-to-end digital thread that connects data from research through to production in Life Sciences • Combined capabilities expected to accelerate scientific innovation and drive long-term growth • Acquisition is another milestone of Siemens’ ONE Tech Company program [...]

BICO has completed the divestment of MatTek and Visikol

ICO has as of today completed the divestment of MatTek and Visikol to Sartorius, for USD 80m on a cash and debt-free basis, after customary regulatory approval has been obtained. Following transaction costs, net debt and working capital adjustments net proceeds are estimated to amount to USD 77.2m. The divestment follows the Group’s updated strategy [...]

4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies

Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market Cambridge, UK – 4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. [...]

Takara Bio Europe signs distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products

Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis [...]

SPECTRO Launches the SPECTROGREEN MS: A Cutting-Edge Quadrupole ICP-MS for Advanced Elemental Analysis

SPECTRO Analytical Instruments has unveiled its new SPECTROGREEN MS Quadrupole Mass Spectrometer, an innovative ICP-MS solution engineered for high-performance, routine trace-level elemental analysis with unmatched ease of use. The SPECTROGREEN MS combines state-of-the-art technology with simplified workflows to address the needs of laboratories handling environmental, pharmaceutical, food, consumer product testing, and industrial applications. Highlights of [...]

Genovis Exercises Call Option to Acquire Remaining Shares in SEQURNA, a fast-growing next-generation RNase inhibitors company

Genovis AB (publ) (“Genovis”) today announces that it has exercised its call option to acquire the remaining 75% of SEQURNA AB (“SEQURNA” or “Company”), a strategic move that accelerates Genovis’ expansion into the fast-growing genomics sector. This acquisition unlocks new product offerings for Genovis to both existing and new customers and further paves the way [...]

Siemens completes acquisition of Dotmatics

Acquisition successfully closed for enterprise value of $5.1 billion Siemens expands AI-powered Siemens Xcelerator portfolio with end-to-end digital thread that connects data from research through to production in Life Sciences Combined capabilities expected to accelerate scientific innovation and drive long-term growth Acquisition is another milestone of Siemens' ONE Tech Company program expanding Siemens' offerings into the [...]

PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan

 Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development -- TOKYO -- The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHCbi"), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as "PHCHD") announces it has signed an exclusive agreement with MaxCyte, Inc. [...]

Ad hoc announcement pursuant to Art. 53 LR — Zeochem to acquire SiliCycle of Canada

The Chemistry Division of the CPH Group has entered into an agreement to purchase all substantial assets of SiliCycle Inc., a Canada-based company. The acquisition of this manufacturer of high-value chromatography gels for the pharmaceutical industries marks a further milestone in the CPH Group’s implementation of its global expansion strategy. Perlen – The CPH Group [...]

Access IBO on Knowledge Center